Albert Bourla
Albert Bourla is the CEO of Pfizer, a leading global pharmaceutical company. He gained significant recognition for his leadership during the COVID-19 pandemic, particularly for spearheading the rapid development of the vaccine. Recently, he has indicated Pfizer's focus on oral medications for obesity treatments, acknowledging the company's late entry into the injectable space.
Born on Oct 21, 1961 (63 years old)
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| United States | 12 | 5.42 | 0.27% | +10% | 331,002,651 | 986,283 | $21,000,000 | 62,573$ |
| Serbia | 4 | 5.25 | 0.20% | +0% | 8,737,371 | 17,850 | $55,000 | 112$ |
| Croatia | 3 | 5.33 | 0.15% | +0% | 4,105,267 | 6,329 | $68,000 | 105$ |
| North Macedonia | 3 | 5.33 | 0.29% | +0% | 2,083,374 | 5,970 | $12,800 | 37$ |
| Hungary | 2 | 5.00 | 0.15% | +0% | 9,660,351 | 14,134 | $160,000 | 234$ |
| Luxembourg | 2 | 5.50 | 0.14% | +0% | 625,978 | 887 | $73,000 | 103$ |
| Canada | 1 | 5.00 | 0.06% | +0% | 38,005,238 | 21,044 | $1,700,000 | 941$ |
| United Kingdom | 1 | 5.00 | 0.03% | +0% | 67,886,011 | 21,927 | $2,700,000 | 872$ |
| France | 1 | 5.00 | 0.06% | +0% | 65,273,511 | 37,687 | $2,700,000 | 1,559$ |
| Italy | 1 | 5.00 | 0.05% | +0% | 60,461,826 | 30,943 | $2,000,000 | 1,024$ |
| Switzerland | 1 | 5.00 | 0.07% | +0% | 8,654,622 | 5,627 | $700,000 | 455$ |
| Portugal | 1 | 5.00 | 0.06% | +0% | 10,196,709 | 5,719 | $240,000 | 135$ |
| Romania | 1 | 5.00 | 0.05% | +0% | 19,237,691 | 9,820 | $250,000 | 128$ |
| Bulgaria | 1 | 5.00 | 0.10% | +0% | 6,948,445 | 7,076 | $69,000 | 70$ |
| Russia | 1 | 5.00 | 0.05% | +0% | 144,104,080 | 76,367 | $1,500,000 | 795$ |
| Slovakia | 1 | 5.00 | 0.05% | +0% | 5,459,642 | 2,814 | $110,000 | 57$ |
| Lithuania | 1 | 6.00 | 0.05% | +0% | 2,722,289 | 1,424 | $54,000 | 28$ |
| Slovenia | 1 | 5.00 | 0.08% | +0% | 2,078,938 | 1,599 | $56,000 | 43$ |
| Montenegro | 1 | 6.00 | 0.05% | +0% | 628,066 | 340 | $5,500 | 3$ |
| Monaco | 1 | 5.00 | 0.08% | +0% | 39,242 | 30 | $7,800 | 6$ |
| Ireland | 1 | 5.00 | 0.05% | +0% | 5,030,000 | 2,631 | $5,100 | 3$ |
| Totals | 41 | 792,941,302 | 1,256,501 | $33,466,200 | 69,283$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United States:
'We agree to disagree': Pfizer CEO on working with HHS despite vaccine views.
5
United States:
Pfizer CEO Albert Bourla discusses working with HHS despite differing vaccine views.
5
United States:
'We agree to disagree': Pfizer CEO on working with HHS despite vaccine views.
5
United States:
'We agree to disagree': Pfizer CEO on working with HHS despite vaccine views.
5
United States:
'We agree to disagree': Pfizer CEO on working with HHS despite vaccine views.
5
United States:
'We agree to disagree': Pfizer CEO on working with HHS despite vaccine views.
5
United States:
Albert Bourla, Pfizer CEO, discusses working with HHS despite differing vaccine views.
6
United States:
Pfizer CEO Albert Bourla discusses working with HHS despite vaccine views.
5
United States:
'We agree to disagree': Pfizer CEO on working with HHS despite vaccine views.
5
United States:
Dr. Albert Bourla is the CEO of Pfizer and discussed the advancements in targeted cancer therapies during the presentation of new data on colorectal cancer treatment.
9